Dr. María José Torres, Head of the Allergology Department of the HRU of Malaga, new President of the EAACI
La Dra. María José Torres, jefa de Servicio de Alergología del HRU de Málaga, nueva presidenta de la EAACI VALENCIA, España, June 04, 2024 (GLOBE NEWSWIRE) -- Se ha llevado a cabo el acto de clausura del Congreso EAACI 2024, foro de encuentro para los expertos en Alergia e Inmunología venidos de...
Dr. María José Torres, Head of the Allergology Department of the HRU of Malaga, new President of the EAACI
Dr. María José Torres, Head of the Allergology Department of the HRU of Malaga, new President of the EAACI La Dra. María José Torres, jefa de Servicio de Alergología del HRU de Málaga, nueva presidenta de la EAACI
Allergic diseases directly cost between 1,800 and 6,600 euros per patient per year
Las enfermedades alérgicas suponen un coste directo de entre 1.800 y 6.600 euros por paciente al año VALENCIA, España, June 02, 2024 (GLOBE NEWSWIRE) -- Las enfermedades alérgicas suponen un coste de entre 1.823 y 6.656 euros por paciente al año si solo tenemos en cuenta los gastos directos...
Allergic diseases directly cost between 1,800 and 6,600 euros per patient per year
Allergic diseases directly cost between 1,800 and 6,600 euros per patient per year Allergic diseases directly cost between 1,800 and 6,600 euros per patient per year
EAACI Congress Kicks Off in Valencia, Spain
Arranca en Valencia el Congreso de la EAACI VALENCIA, España, May 31, 2024 (GLOBE NEWSWIRE) -- Con el lema “Revolucionando la atención al paciente a través del poder de la ciencia de los datos”, ha comenzado el congreso internacional...
EAACI Congress Kicks Off in Valencia, Spain
EAACI Congress Kicks Off in Valencia, Spain EAACI Congress Kicks Off in Valencia, Spain Precision Medicine, Immunotherapy, and Artificial Intelligence (AI) as Key Topics
22157.jpg
Allergy Vaccine Market Trends, Forecast and Competitive Analysis: A $3.6 Billion Market by 2030 with a CAGR of 7.5% from 2024 to 2030
May 31, 2024 04:18 ET | Research and Markets
Dublin, May 31, 2024 (GLOBE NEWSWIRE) -- The "Allergy Vaccine Market Report: Trends, Forecast and Competitive Analysis to 2030" report has been added to ResearchAndMarkets.com's offering.The global...
EAACI Congress 2024
Presentación del Congreso de la Academia Europea de Alergología e Inmunología Clínica (EAACI) que se celebrará en Valencia del 31 de mayo al 3 de junio VALENCIA, España, May 30, 2024 (GLOBE NEWSWIRE) -- Con el lema «Revolucionando la atención al paciente a través del poder de la ciencia de los datos», el congreso destacará el papel...
EAACI Congress 2024
Presentation of the Congress of the European Academy of Allergy and Clinical Immunology (EAACI) to be held in Valencia from May 31 to June 3 We are delighted to invite you to the opening press conference of our EAACI Annual Congress 2024 in Valencia or online via the link below.
download.png
Altamira Therapeutics Announces Dissemination of Positive Results from Bentrio Trial in Seasonal Allergic Rhinitis Through Social Media Channels of Top Allergy Journal
May 23, 2024 08:47 ET | Altamira Therapeutics Ltd
Hamilton, Bermuda, May 23, 2024 (GLOBE NEWSWIRE) -- HAMILTON, BERMUDA – May 23, 2024 -- Altamira Therapeutics Ltd. (“Altamira” or the “Company”) (Nasdaq:CYTO), a company dedicated to developing and...